Horizon Technology Finance Announces Monthly Dividends for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Horizon Technology Finance Announces Monthly Dividends for October, November and December 2013 Totaling $0.345 Per Share

FARMINGTON, Conn., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Horizon Technology Finance Corporation (Nasdaq: HRZN ) (the "Company" or "Horizon"), a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and clean-tech industries, announced today that its Board of Directors declared monthly dividends of $0.115 per share for each of October, November and December 2013. These monthly dividends, which will be payable in the fourth quarter of 2013 as set forth in the table below, total $0.345 per share. Including the monthly dividends declared in the third quarter of 2013, Horizon has declared $4.58 per share in cumulative dividends since its October 2010 initial public offering.

Monthly Dividends Declared in Third Quarter 2013

Declared Ex-Dividend Date Record Date Payment Date Amount Per Share
August 2, 2013 September 16, 2013 September 18, 2013 October 15, 2013 $0.115
August 2, 2013 October 15, 2013 October 17, 2013 November 15, 2013 $0.115
August 2, 2013 November 15, 2013 November 19, 2013 December 16, 2013 $0.115
  Total: $0.345

When declaring dividends, the Horizon Board of Directors reviews estimates of taxable income available for distribution, which may differ from consolidated net income under generally accepted accounting principles due to (i) changes in unrealized appreciation and depreciation, (ii) temporary and permanent differences in income and expense recognition, and (iii) the amount of spillover income carried over from a given year for distribution in the following year. The final determination of taxable income for each tax year, as well as the tax attributes for dividends in such tax year, will be made after the close of the tax year.

Horizon maintains a dividend reinvestment plan ("DRIP") that provides for the reinvestment of dividends on behalf of its stockholders, unless a stockholder has elected to receive dividends in cash. As a result, if Horizon declares a dividend, its stockholders who have not "opted out" of the DRIP by the dividend record date will have their dividend automatically reinvested into additional shares of Horizon's common stock.  Horizon has the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.  Newly-issued shares will be valued based upon the final closing price of Horizon's common stock on a specified valuation date for each dividend as determined by Horizon's Board of Directors.  Shares purchased in the open market to satisfy the DRIP requirements will be valued based upon the average price of the applicable shares purchased by the DRIP plan administrator, before any associated brokerage or other costs, which are borne by Horizon.

About Horizon Technology Finance

Horizon Technology Finance Corporation is a business development company that provides secured loans to development-stage companies backed by established venture capital and private equity firms within the technology, life science, healthcare information and services, and clean-tech industries. The investment objective of Horizon is to maximize total risk-adjusted returns by generating current income from a portfolio of directly originated secured loans as well as capital appreciation from warrants to purchase the equity of portfolio companies. Headquartered in Farmington, Connecticut, with regional offices in Walnut Creek, California and Reston, Virginia, Horizon is externally managed by its investment advisor, Horizon Technology Finance Management LLC. Horizon's common stock trades on the NASDAQ Global Select Market under the ticker symbol "HRZN". In addition, Horizon's 7.375% Senior Notes due 2019 trade on the New York Stock Exchange under the ticker symbol "HTF." To learn more, please visit www.horizontechnologyfinancecorp.com .

Forward-Looking Statements

Statements included herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in our filings with the Securities and Exchange Commission. Horizon undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

Horizon Technology Finance Corporation Christopher M. Mathieu Chief Financial Officer (860) 676-8653 Investor Relations and Media Contacts: The IGB Group Michael Cimini / Leon Berman (212) 477-8261 / (212) 477-8438 /

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ARTBOX Brings Korean Lifestyle Magic to LA Pop-Up

Updated Category News Views 3

ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...

Continue Reading
Monster Energy Dominates Skateboard Podium at SLS Paris

Updated Category News Views 3

Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...

Continue Reading
Monteverde Probes Four Key M&A Deals for Fairness

Updated Category News Views 4

Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...

Continue Reading
Monteverde's Equity Alert: Scrutinizing Recent M&A Deals

Updated Category News Views 3

Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...

Continue Reading
Blokees Unveils 90+ New Wonders at Shanghai Fest

Updated Category News Views 3

A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...

Continue Reading
Lawsuit Highlights Inaction in School Bus Tragedy

Updated Category News Views 3

Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...

Continue Reading
Black Culture Icon: Plastic-Covered Couch Takes Stage

Updated Category News Views 3

A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...

Continue Reading
Power Knot MEA Wins THE BIZZ 2026 for Excellence

Updated Category News Views 3

Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...

Continue Reading
Class Action Alerts: M&A Under Scrutiny

Updated Category News Views 3

Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...

Continue Reading
SiBionics and PharmaSens Unveil Diabetes Tech at EASD

Updated Category News Views 2

Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Voya Financial's Expected Earnings Results

Updated Category News Views 152

Voya Financial's Earnings: What to Anticipate Voya Financial (NYSE: VOYA) is on the brink of unveiling its quarterly earnings, and there are important factors for investors to consider ahead of this crucial announcement. Understanding Expectations Analysts project Voya Financial will report an earnings per share (EPS) of $2.24. This figure sets the stage for anticipation...

Continue Reading
Innovative Teddy Bear Aims to Support Autistic Children

Updated Category News Views 330

New Approach to Comfort for Autistic Children In an inspiring move to support children with autism, an inventor from White Pine has developed an innovative teddy bear, specifically designed to provide comfort and companionship. This creation, known as the Autistic Teddy Bear, emerges from a heartfelt desire to offer a huggable, vibrant friend for children on the autism...

Continue Reading
Shopoff Realty Investments Gains Key Approval for Housing Project

Updated Category News Views 156

Shopoff Realty Investments Secures Project Approval Shopoff Realty Investments, a notable player in the real estate sector, has received unanimous approval from the local planning commission for its ambitious Euclid + Heil project. This key milestone marks a significant step forward in addressing the housing challenges many communities face today. Overview of the Euclid +...

Continue Reading
Record High New-Vehicle Prices: Kelley Blue Book Insights

Updated Category News Views 230

Record High for New-Vehicle Average Transaction Prices In a significant milestone for the automotive market, the average transaction price (ATP) for new vehicles in the United States has exceeded $50,000 for the first time, according to recent estimates. This important data sheds light on the ongoing changes and trends influencing vehicle pricing, primarily driven by...

Continue Reading
Cognition Therapeutics Reaches Milestone in Alzheimer’s Study

Updated Category News Views 145

Cognition Therapeutics Hits Milestone in Alzheimer's Research Cognition Therapeutics, Inc. (NASDAQ: CGTX), based in Purchase, N.Y., recently announced an important milestone in its clinical research for zervimesine (CT1812) as part of the Phase 2 START Study. This study, aimed at addressing early Alzheimer’s disease, has successfully surpassed the 50% enrollment target,...

Continue Reading